Plerixafor

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 982 publications

Lenalidomide exposure duration and drug holidays do not affect stem cell mobilisation with plerixafor and G-CSF in multiple myeloma.

Lenalidomide exposure duration and drug holidays do not affect stem cell mobilisation with plerixafor and G-CSF in multiple myeloma.

Journal: Leukemia & lymphoma

Published: April 01, 2026

A multi-stage computational pipeline and in vitro validation for the discovery of small-molecule translation inhibitors targeting the bacterial ribosome.

A multi-stage computational pipeline and in vitro validation for the discovery of small-molecule translation inhibitors targeting the bacterial ribosome.

Journal: RSC advances

Published: March 02, 2026

WBC Growth Factors: ASCO Guideline Update.

WBC Growth Factors: ASCO Guideline Update.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 25, 2026

Steady-state mobilization with on-demand plerixafor after CD38 antibody-based induction in multiple myeloma patients.

Steady-state mobilization with on-demand plerixafor after CD38 antibody-based induction in multiple myeloma patients.

Journal: Transfusion

Published: February 24, 2026

Stem cell mobilization with plerixafor in pediatric solid tumors patients: a single-center study

Stem cell mobilization with plerixafor in pediatric solid tumors patients: a single-center study

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: February 01, 2026

Feasibility of Salvage Therapy With High-Dose Bendamustine and Rituximab Based on a Series of Two Cases From a Planned Phase II Trial for Relapsed/Refractory Diffuse Large B-cell Lymphoma.

Feasibility of Salvage Therapy With High-Dose Bendamustine and Rituximab Based on a Series of Two Cases From a Planned Phase II Trial for Relapsed/Refractory Diffuse Large B-cell Lymphoma.

Journal: Cureus

Published: January 29, 2026

World Marrow Donor Association Statement on the Use of Plerixafor in Healthy Donors.

World Marrow Donor Association Statement on the Use of Plerixafor in Healthy Donors.

Journal: Transplantation and cellular therapy

Published: January 10, 2026

Cost-utility of pre-emptive plerixafor versus rescue plerixafor in the mobilization of hematopoietic stem cells in multiple myeloma.

Cost-utility of pre-emptive plerixafor versus rescue plerixafor in the mobilization of hematopoietic stem cells in multiple myeloma.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: January 08, 2026

Effect of different induction chemotherapy regimens on autologous hematopoietic stem cell mobilization in patients with multiple myeloma in the new drug era

Effect of different induction chemotherapy regimens on autologous hematopoietic stem cell mobilization in patients with multiple myeloma in the new drug era

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: January 05, 2026

EPI-X4 is a peptide antagonist of CXCR4 with therapeutic prospects for cancer and inflammatory disorders.

EPI-X4 is a peptide antagonist of CXCR4 with therapeutic prospects for cancer and inflammatory disorders.

Journal: Peptides

Published: December 29, 2025

Safety and efficacy of G-CSF alone with pre-emptive plerixafor for autologous peripheral blood hematopoietic stem cell mobilization in newly diagnosed multiple myeloma.

Safety and efficacy of G-CSF alone with pre-emptive plerixafor for autologous peripheral blood hematopoietic stem cell mobilization in newly diagnosed multiple myeloma.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: December 24, 2025

Cyp7b1-inhibiting azoles enhance hematopoietic stem and progenitor cell mobilization in normal and sickle cell disease mice.

Cyp7b1-inhibiting azoles enhance hematopoietic stem and progenitor cell mobilization in normal and sickle cell disease mice.

Journal: Haematologica

Published: November 25, 2025

Showing 1-12 of 982

Last Updated: 04/28/2026